Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bart Staels

Showing results (281-290 of 594) with videos related to

Pageof 60
Sort By:
The Biochemical Journal|November 9, 2007
Activators of the farnesoid X receptor negatively regulate androgen glucuronidation in human prostate cancer LNCAP cellsJenny Kaeding, Emmanuel Bouchaert, Julie Bélanger, et al.
Molecular Pharmacology|October 8, 2004
Hepatic expression of the UGT1A9 gene is governed by hepatocyte nuclear factor 4alphaOlivier Barbier, Hugo Girard, Yusuke Inoue, et al.
Atherosclerosis|February 10, 2009
On the mechanism for PPAR agonists to enhance ABCA1 gene expressionMasaki Ogata, Maki Tsujita, Mohammad Anwar Hossain, et al.
Diabetes|May 3, 2014
Cdkn2a/p16Ink4a regulates fasting-induced hepatic gluconeogenesis through the PKA-CREB-PGC1α pathwayKadiombo Bantubungi, Sarah-Anissa Hannou, Sandrine Caron-Houde, et al.
Endocrinology|January 19, 2012
Peroxisome proliferator-activated receptors-α and -γ, and cAMP-mediated pathways, control retinol-binding protein-4 gene expression in brown adipose tissueMeritxell Rosell, Elayne Hondares, Sadahiko Iwamoto, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|December 18, 2012
Role of proinflammatory CD68(+) mannose receptor(-) macrophages in peroxiredoxin-1 expression and in abdominal aortic aneurysms in humansLudovic Boytard, Rafaelle Spear, Giulia Chinetti-Gbaguidi, et al.
Cardiovascular Pathology : the Official Journal of the Society for Cardiovascular Pathology|April 26, 2008
Beneficial effects of fenofibrate on plaque thrombogenicity and plaque stability in atherosclerotic rabbitsEmmanuelle Jeanpierre, Thierry Le Tourneau, Christophe Zawadzki, et al.
Frontiers in Immunology|August 27, 2019
Mechanisms Underlying the Functional Cooperation Between PPARα and GRα to Attenuate Inflammatory ResponsesNadia Bougarne, Viacheslav Mylka, Dariusz Ratman, et al.
Bioorganic & Medicinal Chemistry Letters|April 27, 2024
Synthesis of a new 2-prenylated quinoline as potential drug for metabolic syndrome with pan-PPAR activity and anti-inflammatory effectsCarlos Villarroel-Vicente, Ainhoa García, Khamis Zibar, et al.
Hepatology (Baltimore, Md.)|July 28, 2006
The liver X-receptor alpha controls hepatic expression of the human bile acid-glucuronidating UGT1A3 enzyme in human cells and transgenic miceMélanie Verreault, Kathy Senekeo-Effenberger, Jocelyn Trottier, et al.
Pageof 60

Showing results (281-290 of 594) with videos related to

Sort By:
Pageof 60
The Biochemical Journal|November 9, 2007
Activators of the farnesoid X receptor negatively regulate androgen glucuronidation in human prostate cancer LNCAP cellsJenny Kaeding, Emmanuel Bouchaert, Julie Bélanger, et al.
Molecular Pharmacology|October 8, 2004
Hepatic expression of the UGT1A9 gene is governed by hepatocyte nuclear factor 4alphaOlivier Barbier, Hugo Girard, Yusuke Inoue, et al.
Atherosclerosis|February 10, 2009
On the mechanism for PPAR agonists to enhance ABCA1 gene expressionMasaki Ogata, Maki Tsujita, Mohammad Anwar Hossain, et al.
Diabetes|May 3, 2014
Cdkn2a/p16Ink4a regulates fasting-induced hepatic gluconeogenesis through the PKA-CREB-PGC1α pathwayKadiombo Bantubungi, Sarah-Anissa Hannou, Sandrine Caron-Houde, et al.
Endocrinology|January 19, 2012
Peroxisome proliferator-activated receptors-α and -γ, and cAMP-mediated pathways, control retinol-binding protein-4 gene expression in brown adipose tissueMeritxell Rosell, Elayne Hondares, Sadahiko Iwamoto, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|December 18, 2012
Role of proinflammatory CD68(+) mannose receptor(-) macrophages in peroxiredoxin-1 expression and in abdominal aortic aneurysms in humansLudovic Boytard, Rafaelle Spear, Giulia Chinetti-Gbaguidi, et al.
Cardiovascular Pathology : the Official Journal of the Society for Cardiovascular Pathology|April 26, 2008
Beneficial effects of fenofibrate on plaque thrombogenicity and plaque stability in atherosclerotic rabbitsEmmanuelle Jeanpierre, Thierry Le Tourneau, Christophe Zawadzki, et al.
Frontiers in Immunology|August 27, 2019
Mechanisms Underlying the Functional Cooperation Between PPARα and GRα to Attenuate Inflammatory ResponsesNadia Bougarne, Viacheslav Mylka, Dariusz Ratman, et al.
Bioorganic & Medicinal Chemistry Letters|April 27, 2024
Synthesis of a new 2-prenylated quinoline as potential drug for metabolic syndrome with pan-PPAR activity and anti-inflammatory effectsCarlos Villarroel-Vicente, Ainhoa García, Khamis Zibar, et al.
Hepatology (Baltimore, Md.)|July 28, 2006
The liver X-receptor alpha controls hepatic expression of the human bile acid-glucuronidating UGT1A3 enzyme in human cells and transgenic miceMélanie Verreault, Kathy Senekeo-Effenberger, Jocelyn Trottier, et al.
Pageof 60